Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from February 24, 2020 up to and including February 27, 2020 a total of 475,000 of its own common shares were repurchased, with a weighted average purchase price of EUR 40.42. These repurchases were made under the repurchase program for capital reduction purposes, which was announced on January 29, 2019. Further details can be found via this link.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office Tel: +31 6 1521 3446
You are about to visit a Philips global content page
Continue Philips Investor Relations Tel.: +31 20 59 77222
Get our press releases by e-mail
You are about to visit a Philips global content page
Continue